|
EARS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.79959999627266E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.794900E-04 |
| Normal-vs-Stage2 |
1.152990E-01 |
| Normal-vs-Stage3 |
9.464300E-03 |
| Normal-vs-Stage4 |
1.251610E-01 |
| Stage1-vs-Stage2 |
8.617400E-01 |
| Stage1-vs-Stage3 |
2.131600E-01 |
| Stage1-vs-Stage4 |
9.036000E-01 |
| Stage2-vs-Stage3 |
5.112000E-01 |
| Stage2-vs-Stage4 |
9.917800E-01 |
| Stage3-vs-Stage4 |
5.686400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.27559995688875E-09 |
| Normal-vs-AfricanAmerican |
8.908300E-02 |
| Normal-vs-Asian |
8.545400E-01 |
| Caucasian-vs-AfricanAmerican |
3.362100E-03 |
| Caucasian-vs-Asian |
1.623980E-01 |
| AfricanAmerican-vs-Asian |
4.509800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.6473000033015E-08 |
| Normal-vs-Female |
1.397950E-03 |
| Male-vs-Female |
8.588800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.662580E-01 |
| Normal-vs-Extreme_Weight |
2.258700E-03 |
| Normal-vs-Obese |
1.213660E-04 |
| Normal-vs-Extreme_Obese |
2.542000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.365200E-01 |
| Normal_Weight-vs-Obese |
8.758400E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.131800E-01 |
| Extreme_Weight-vs-Obese |
3.860000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.375400E-01 |
| Obese-vs-Extreme_Obese |
9.347200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.558100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.16459999999863E-05 |
| Normal-vs-Age(61-80Yrs) |
1.63783000000084E-05 |
| Normal-vs-Age(81-100Yrs) |
2.013400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.760600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.807200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.919200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.914800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.767800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.894400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.92219999994858E-06 |
| Normal-VS-Type2 PRCC |
3.407700E-04 |
| Normal-VS-KIRP CIMP |
6.279900E-02 |
| Normal-VS-Unclassified PRCC |
1.019410E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.113000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.534400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.028600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.120800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.475400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.925800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.677560E-02 |
| Normal-vs-N1 |
1.074040E-02 |
| Normal-vs-N2 |
2.784600E-01 |
| N0-vs-N1 |
6.495600E-01 |
| N0-vs-N2 |
5.796800E-01 |
| N1-vs-N2 |
6.891600E-01 |
|
|
